# Evaluation of the Use of a Probiotic Containing Bifidobacterium Breve PRL2020 in Oral Drops in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic Use

> **NCT07234448** · NA · NOT_YET_RECRUITING · sponsor: **Liaquat University of Medical & Health Sciences** · enrollment: 1000 (estimated)

## Conditions studied

- Antibiotic-associated Diarrhea

## Interventions

- **DIETARY_SUPPLEMENT:** Brevicillin® gocce (Bifidobacterium breve PRL2020)
- **OTHER:** Placebo (matching oil drops)

## Key facts

- **NCT ID:** NCT07234448
- **Lead sponsor:** Liaquat University of Medical & Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-05-29
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07234448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07234448, "Evaluation of the Use of a Probiotic Containing Bifidobacterium Breve PRL2020 in Oral Drops in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic Use". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07234448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*